Sonova Holding (OTCMKTS:SONVY) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Sonova Holding (OTCMKTS:SONVY) have earned an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation, one has assigned a buy recommendation and two have issued a strong buy recommendation on the company.

SONVY has been the topic of a number of research reports. Zacks Research raised Sonova from a “strong sell” rating to a “hold” rating in a research report on Monday, February 9th. BNP Paribas Exane upgraded shares of Sonova from a “strong sell” rating to a “strong-buy” rating in a research note on Tuesday, March 10th. Finally, Jefferies Financial Group downgraded shares of Sonova from a “hold” rating to a “moderate sell” rating in a report on Wednesday.

Sonova Trading Down 0.5%

Shares of OTCMKTS:SONVY opened at $45.66 on Friday. The company has a current ratio of 1.24, a quick ratio of 0.91 and a debt-to-equity ratio of 0.51. Sonova has a 52-week low of $45.13 and a 52-week high of $68.76. The business’s 50 day simple moving average is $52.20 and its two-hundred day simple moving average is $53.36.

Sonova Company Profile

Sonova AG (OTCMKTS:SONVY) is a Switzerland-based provider of hearing care solutions, headquartered in Stäfa. The company designs, develops, manufactures and distributes a range of audiological products and related services aimed at improving hearing and communication for people with hearing loss. Its portfolio spans behind-the-ear and in-the-ear hearing instruments, wireless accessories and software solutions that enable connectivity with consumer devices and audiological fittings.

Sonova markets its products under several well-known brands, including Phonak and Unitron for hearing aids, and it is also associated with Advanced Bionics for cochlear implant systems.